Dammam, Saudi Arabia

Ayman A Elbadry

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ayman A Elbadry: Innovator in Nanomedicine

Introduction

Ayman A Elbadry is a prominent inventor based in Dammam, Saudi Arabia. He has made significant contributions to the field of nanomedicine, holding a total of 3 patents. His work focuses on developing innovative solutions for treating infections through advanced nanomedicinal compositions.

Latest Patents

Elbadry's latest patents include a method for forming a nanomedicinal composition that comprises a nanocarrier and an antioxidant. The nanocarrier is designed with a metal organic framework and a porous silicate and/or aluminosilicate matrix. The antioxidant is strategically placed in the pores and/or on the surface of the nanocarrier using a solution phase impregnation process. This composition is particularly useful in treating infections. Another notable patent is a method for treating Blastocystis infection, which utilizes a similar nanomedicinal composition to combat this specific infection effectively.

Career Highlights

Ayman A Elbadry is affiliated with Imam Abdulrahman Bin Faisal University, where he continues to advance his research in nanomedicine. His academic and professional journey reflects a commitment to innovation and the application of scientific principles to real-world health challenges.

Collaborations

Elbadry has collaborated with notable colleagues, including B Rabindran Jermy and Vijaya Ravinayagam. These partnerships enhance the research and development of his innovative solutions in the field of nanomedicine.

Conclusion

Ayman A Elbadry stands out as a key figure in the realm of nanomedicine, with his patents paving the way for new treatment methodologies. His dedication to research and collaboration underscores the importance of innovation in addressing health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…